Cajutol, Benedicto D.

HRN: 09-06-25  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2022
CEFTRIAXONE 1G (VIAL)
09/17/2022
09/23/2022
IV
2g
OD
Pneumonia
Waiting Final Action 
10/12/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/12/2022
10/19/2022
IVTT
1.5
Q8
Aspiration Pneumonia
Waiting Final Action 
10/16/2022
CEFTAZIDIME 1GM (VIAL)
10/16/2022
10/22/2022
IV
1g
Q8
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: